CMS Open Payments · Program Year 2024
Escala Medical Inc.
Escala Medical Inc. reported $6,029.53 across General Payments, Research, and Ownership to 52 physicians and teaching hospitals across 52 transactions.
- $6.0K Below-median payer
- All-tracks total
- 52 Below-median volume
- Transactions
- 52 Below-median reach
- Recipients
- #1696
- of 1,925 companies
Escala Medical Inc. reported $6,029.53 across all CMS Open Payments tracks (General + Research + Ownership) to 52 physicians and teaching hospitals in Program Year 2024 - ranking #1696 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $6,029.53, averaging $115.95 per recipient.
Escala Medical Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
10/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
10/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer escala-medical-inc Escala Medical Inc.
$6.0K · #1696/1,925 · 0.0% industry · PY2024
- TOT $6.0K
- RANK #1696
- SHARE 0.0%
- TXN 52
- RCP 52
- CAT 1
- GEN $6.0K
- TOP1 5.5%
- PY 2024
Volume peers
Nearest volume peer: Dunamis Medical, LLC ($6.0K)
Escala Medical Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Escala Medical Inc.
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Escala Medical Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
Of the 1 general-payment categories charted below, "Food and Beverage" is the largest at $6.0K across 52 transactions, 100.0% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Food and Beverage" leads Escala Medical Inc.'s 1-category general-payment breakdown at $6.0K, 100.0% of the reported total.
How Escala Medical Inc. divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Food and Beverage | $6.0K | 52 | 100.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,001.61 (16.6%) of $6,029.53 in this company's General Payments records across 49 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Escala Medical Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Dr. Michael Vardy
$330.57 across 2 reported transactions
- 2
Dr. Michael Douso
$167.76 across 1 reported transactions
- 3
Nani Moss
$167.76 across 1 reported transactions
- 4
Dr. GREGORY FASANI-FELDBERG
$167.76 across 1 reported transactions
- 5
Dr. Bruce Kaufmann
$167.76 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Escala Medical Inc.'s spend rank (#1696 of 1,925, bottom 12% by spend) and concentration rank (#1,496 of 1,838, bottom 19% least concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Essential Dental Systems Incorporated : $2.7K total payments, HHI 269
- Shape Memory Medical Inc. : $25.2K total payments, HHI 268
- La Jolla Pharmaceutical Company : $486.9K total payments, HHI 268
- Eurofins Viracor, LLC : $6.3K total payments, HHI 267
- Terumo Medical Corporation : $1.2M total payments, HHI 267
- Aveo Pharmaceuticals, Inc. : $486.7K total payments, HHI 267
- Escala Medical Inc. (this company) : $6.0K total payments, HHI 266
- Elucent Medical : $251.3K total payments, HHI 265
- AltaThera Pharmaceuticals LLC : $230.3K total payments, HHI 265
- Team 1, Llc : $78.3K total payments, HHI 263
- ConvaTec Inc. : $8.5M total payments, HHI 261
- Avita Medical Americas, Llc : $545.0K total payments, HHI 257
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Escala Medical Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Escala Medical Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Escala Medical Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
DentalEZ Alabama, Inc.
Alliance Medical
Dynasplint Systems Inc.
ReShape Lifesciences Inc.
Perfuze Inc
Put this to use
Escala Medical Inc. ranks #1696 of 1,925 by all-tracks total payments, led by "Food and Beverage".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Food and Beverage" spend across every manufacturer, not just Escala Medical Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.